Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy

Ear Nose Throat J. 2024 Feb;103(2):100-101. doi: 10.1177/01455613211040578. Epub 2021 Aug 15.

Abstract

Recurrent respiratory papillomatosis is a condition caused by human papilloma virus, usually sub types 6 and 11. Papillomas are benign neoplasms that are most commonly found on the larynx and can be often associated with significant airway involvement. Frequency of episodes varies among patients as do the clinical symptoms. Patients often present with symptoms such as hoarseness but there is potential for respiratory compromise and even complete airway obstruction.

Publication types

  • Review

MeSH terms

  • Bevacizumab / therapeutic use
  • Humans
  • Larynx*
  • Papillomavirus Infections* / complications
  • Papillomavirus Infections* / drug therapy
  • Respiratory Tract Infections* / complications
  • Respiratory Tract Infections* / drug therapy

Substances

  • Bevacizumab

Supplementary concepts

  • Recurrent respiratory papillomatosis